Stigma as a barrier to the elimination of vertical HIV transmission: model projections from an urban Prevention of Mother to Child Transmission (PMTCT) programme in South Africa by Prudden, H et al.
Prudden, H; Dzialowy, N; Foss, A; Black, V; Stoeckl, H; Wallace, N;
Monfiston, P; Zimmerman, C; Watts, C; Nyblade, L (2012) Stigma
as a barrier to the elimination of vertical HIV transmission: model
projections from an urban Prevention of Mother to Child Transmis-
sion (PMTCT) programme in South Africa. In: UNSPECIFIED.
Downloaded from: http://researchonline.lshtm.ac.uk/21164/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial
http://creativecommons.org/licenses/by-nc/2.5/
Presented at AIDS 2012—Washington, DC, USA
Stigma as a Barrier to the Elimination of New Infant Infections: 
Model Projections from an Urban PMTCT Program in South Africa
Holly Prudden,1 Nicole Dzialowy,1 Anna Foss,1 Vivian Black,2 Heidi Stöckl,1 Nathan Wallace,3 
Philippe Monfiston,3 Cathy Zimmerman,1 Charlotte Watts,1 Laura Nyblade4
1London School of Hygiene and Tropical Medicine, 2Wits Reproductive Health and HIV Institute (WRHI), 3Futures Group, 4RTI International
HEALTH
POL ICY
P R O J E C T
Introduction
•	 Stigma	and	resulting	discrimination,	whether	experienced	or	anticipated,	have	been	documented	as	powerful	
barriers	to	uptake	and	retention	in	programs	providing	pregnant	women	living	with	HIV	with	services	to	
prevent	child	infection	and	maternal	deaths.	
•	 However,	the	size	of	the	potential	impact	of	stigma	and	discrimination	on	numbers	of	new	child	infections	and	
therefore	on	investments	in	programs	to	prevent	these	infections	is	unclear.
•	 The	aim	of	this	study	was	to	quantify	the	extent	to	which	mother-to-child	transmissions	(MTCT)	can	be	
attributed	to	stigma	in	an	urban	setting	of	South	Africa.	
Results
•	 Model	projections	show	that	if	stigma	could	be	reduced	to	“minimal”	levels,	44	percent	of	all	vertical	
transmissions	may	be	averted,	with	interquartile	range	(IQR)	estimating	38–46	percent.	
•	 In	addition,	if	non-stigma-related	barriers	could	be	eradicated,	a	further	48	percent	of	infections	could	be	
averted,	IQR	44–53	percent.	
•	 However,	even	under	ideal	circumstances,	the	model	estimates	infections	would	occur,	because	drug	regimens	
do	not	provide	absolute	protection.	
Conclusions
The	model	projections	suggest	HIV-related	stigma	may	be	an	important	barrier	to	the	elimination	of	vertical	HIV	
transmission.	Alongside	investment	to	strengthen	the	health	system	delivery	of	PMTCT,	interventions	to	address	HIV-
related	stigma	need	to	be	supported.	
Methods
A	static	Excel	worksheet	mathematical	model,	incorporating	the	new	WHO	2009	treatment	guidelines	for	PMTCT,	
was	developed,	and	clinical	program	data	from	a	PMTCT	program	in	Johannesburg	were	used	to	parameterize	the	
model	and	simulate	a	high-functioning	health	system,	in	which	women	are	affected	by	both	stigma	and	non-stigma-
related	barriers.	Non-stigma-related	barriers	include,	for	example,	a	number	of	issues	such	as	healthcare	system	
delivery	barriers,	access	to	care	barriers,	and	incorrect	adherence	to	treatment.
•	 A	comprehensive	literature	review	identified	studies	providing	quantitative	estimates	most	likely	to	reflect	the	
number	of	women	lost	through	PMTCT	as	a	result	of	non-stigma-related	issues,	and	this	was	verified	through	
a	number	of	key	stakeholder	interviews,	provided	additional	evidence	for	the	main	non-stigma-related	barriers	
for	the	setting	in	Johannesburg.
•	 From	these	estimates,	a	hypothetical	“minimal”	stigma	scenario	was	created,	reflecting	only	those	infections	
thought	to	be	attributable	to	non-stigma-related	barriers,	as	well	as	infections	that	result	from	PMTCT	drugs	
not	being	100	percent	effective.
•	 An	“idealized”	scenario	estimated	the	number	of	transmissions	that	occur	solely	because	PMTCT	drugs	
[highly	active	antiretroviral	therapy	(HAART)	only]	are	less	than	100	percent	effective.
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A modeled PMTCT cascade for pregnant women eligible for AZT treatment showing continuation 
rates under Johannesburg’s current, high stigma setting and a projected minimal stigma setting. A 
similar cascade exists for women initiated on HAART treatment. 
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Stigma input parameters showing the absolute percentage of females who are lost from the 
PMTCT cascade at each stage for the three scenarios that were modeled 
Absolute Percentage of Women Lost at Each Stage in the Cascade
Stage Idealized 
Minimal 
Stigma
High 
Stigma
1 Percent of women accessing ANC 100 99 97.8
2 Percent of women offered and accept HIV test, results 100 99.1 93.2
3a Percent of eligible women initiated on treatment (AZT) 100 95 92.3
3b Percent of eligible women initiated on treatment (HAART)
100 80 48
4
Percent of women who adhere to treatment regimen 100 90 65
Percent of women on AZT who give birth with skilled 
attendants
100 96 91.2
Percent of women on AZT who receive proper treatment 
at delivery
100 90 86
5 Percent of infants who take 6 weeks of NVP 100 94 81
6 Percent of women who exclusively breastfeed for 6 months
100 87 50
Conceptual diagram representing the 
number of infections in Johannesburg, 
attributable to different components of 
PMTCT failure.
•	 The	Venn	diagram	illustrates	the	
approach	for	estimating	the	relative	
differences	in	the	number	of	infections	
attributable	to	each	component	of	
PMTCT.	The	difference	between	
the	outer	circle	(high-functioning	
system)	and	the	middle	circle	(minimal	
scenario)	provides	the	relative	
percentage	of	infections	attributable	
to	stigma	alone,	while	the	difference	
between	the	middle	circle	and	the	
innermost	circle	(idealized	circle)	
provides	the	relative	percentage	of	
infections	attributable	to	non-stigma	
factors,	therefore	enabling	estimates	
of	the	relative	percentage	of	infections	
attributable	to	stigma	alone	to	be	
obtained.
The	figure	below	shows	the	relative	percentage	decline	in	females	who	exit	the	PMTCT	at	different	stages	for	the	
minimal	scenario	and	the	high-functioning	health	system	in	Johannesburg.
A schematic representation of the WHO 2009 treatment guidelines for PMTCT, showing different 
stages of the cascade where women may be lost from the process as a result of stigma or non-
stigma-related barriers.
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Uncertainty analysis showing the full range, interquartile range (IQR) and median values projected 
across the model simulations for the percentage of infections attributable to each component of the 
PMTCT programme. Median and IQR values are displayed.
